High Performance Computing White Papers

De Novo Pharmaceuticals Limited Case Study

Overview De Novo Pharmaceuticals (De Novo) is a pioneering drug design company specialising in the development of computational approaches to the automated design of novel drugs. The company has recently completed the installation of a high-performance computing platform from Sun Microsystems, as part of a major project to develop a comprehensive chemoinformatics platform to house designs of potential drugs produced by De Novo's proprietary software. The new technology platform comprises a fully integrated, scalable, 80-node Sun compute farm running De Novo's de novo structure-generator software, Skelgen. High performance computing platform enables De Novo to design novel chemical entities.

Further White Paper Details
PublisherSun Microsystems File FormatPDF, requires Acrobat Rdr 5
Date PublishedNovember 2004 Downloads9
FormatCase Studies   
Topics
Thin clients switch on digitally excluded

Thin clients switch on digitally excluded

Case study: Digital inclusion project tackles social exclusion in Liverpool more

Renault goes multilingual

Renault goes multilingual

Case study: Translation tech turns docs into 23 languages… more


Quick Sitemap Links: